Milestone Pharmaceuticals Inc. (MIST) EBITDA
- 2026-06-30: Basis Reported; EBITDA -$25.57M*; Operating income -$25.63M; Depreciation and amortization $57.00K*.
- 2026-03-31: Basis Reported; EBITDA -$23.61M; Operating income (m); Depreciation and amortization (m).
- 2025-12-31: Basis Reported; EBITDA -$17.22M; Operating income (m); Depreciation and amortization (m).
- 2025-09-30: Basis Reported; EBITDA -$11.80M*; Operating income -$11.83M; Depreciation and amortization $25.00K*.
Complete source-backed ebitda history.
- Available history
- 2018-03-31 to 2026-03-31
- Data captured
Historical EBITDA
EBITDA 3 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2026-06-30 | Reported | -$25.57M* | -$25.63M | $57.00K* | $559.00K | -4574.78%* | $26.00K* | -$22.71M* | $32.00K | $3.51M | $22.65M | (m) |
|---|
| 2026-03-31 | Reported | -$23.61M | (m) | (m) | (m) | -9918.91% | $45.00K | -$16.05M | $14.00K | $3.25M | (m) | (m) |
|---|
| 2025-12-31 | Reported | -$17.22M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2025-09-30 | Reported | -$11.80M* | -$11.83M | $25.00K* | (m) | (m) | $2.00K* | -$9.75M* | (m) | $3.94M | (m) | (m) |
|---|
| 2025-06-30 | Reported | -$12.50M* | -$12.53M | $28.00K* | $0.00 | (m) | $11.00K* | -$12.57M* | $0.00 | $3.67M | $8.86M | (m) |
|---|
| 2025-03-31 | Reported | -$20.5M | (m) | (m) | (m) | (m) | $6.00K | -$13.95M | $0.00 | $4.98M | (m) | (m) |
|---|
| 2024-12-31 | Reported | -$12.32M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2024-09-30 | Reported | -$9.59M* | -$9.62M | $25.00K* | (m) | (m) | $4.00K* | -$7.02M* | (m) | $3.96M | (m) | (m) |
|---|
| 2024-06-30 | Reported | -$9.64M* | -$9.66M | $26.00K* | (m) | (m) | (m) | -$6.05M* | (m) | $2.81M | (m) | (m) |
|---|
| 2024-03-31 | Reported | -$10.45M | (m) | (m) | (m) | (m) | (m) | -$8.93M | (m) | $3.64M | (m) | (m) |
|---|
| 2023-12-31 | Reported | -$13.77M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2023-09-30 | Reported | -$15.34M* | -$15.36M | $24.00K* | (m) | (m) | $18.00K* | -$12.16M* | (m) | $6.72M | (m) | (m) |
|---|
| 2023-06-30 | Reported | -$16.41M* | -$16.44M | $24.00K* | (m) | (m) | $31.00K* | -$10.56M* | (m) | $8.62M | (m) | (m) |
|---|
| 2023-03-31 | Reported | -$15.48M | (m) | (m) | (m) | (m) | $32.00K | -$13.90M | (m) | $10.26M | (m) | (m) |
|---|
| 2022-12-31 | Reported | -$13.74M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2022-09-30 | Reported | -$15.00M* | -$15.03M | $27.00K* | (m) | (m) | $103.00K* | -$11.57M* | (m) | $9.83M | (m) | (m) |
|---|
| 2022-06-30 | Reported | -$16.78M* | -$16.81M | $24.00K* | (m) | (m) | (m) | -$14.09M* | (m) | $10.66M | (m) | (m) |
|---|
| 2022-03-31 | Reported | -$14.02M | (m) | (m) | (m) | (m) | (m) | -$13.95M | (m) | $8.77M | (m) | (m) |
|---|
| 2021-12-31 | Reported | -$16.9M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2021-09-30 | Reported | -$14.25M* | -$14.27M | $24.00K* | (m) | (m) | (m) | -$9.39M* | (m) | $9.73M | (m) | (m) |
|---|
| 2021-06-30 | Reported | $735.00K* | $712.00K | $23.00K* | (m) | (m) | (m) | $1.01M* | (m) | $9.43M | (m) | (m) |
|---|
| 2021-03-31 | Reported | -$12.57M | (m) | (m) | (m) | (m) | (m) | -$12.47M | (m) | $8.60M | (m) | (m) |
|---|
| 2020-12-31 | Reported | -$8.74M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2020-09-30 | Reported | -$12.06M* | -$12.09M | $23.00K* | (m) | (m) | (m) | -$7.33M* | (m) | $8.23M | (m) | -$17.00K |
|---|
| 2020-06-30 | Reported | -$13.08M* | -$13.11M | $25.00K* | (m) | (m) | (m) | -$16.56M* | (m) | $8.62M | (m) | (m) |
|---|
| 2020-03-31 | Reported | -$16.73M | (m) | (m) | (m) | (m) | (m) | -$18.08M | (m) | $11.87M | (m) | (m) |
|---|
| 2019-12-31 | Reported | -$18.87M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2019-09-30 | Reported | -$13.72M* | -$13.72M | $9.00K* | (m) | (m) | $294.00K* | -$8.30M* | (m) | $9.54M | (m) | -$73.00K |
|---|
| 2019-06-30 | Reported | -$14.33M* | -$14.33M | $2.00K* | (m) | (m) | (m) | -$11.52M* | (m) | $10.53M | (m) | -$4.00K |
|---|
| 2019-03-31 | Reported | -$10.93M | (m) | (m) | (m) | (m) | (m) | -$14.73M | (m) | $7.76M | (m) | $22.00K |
|---|
| 2018-12-31 | Reported | -$10.11M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2018-09-30 | Reported | -$5.78M* | -$5.79M | $3.00K* | (m) | (m) | $0.00* | -$5.59M* | (m) | $3.91M | (m) | $0.00* |
|---|
| 2018-06-30 | Reported | -$3.67M* | -$3.68M | $3.00K* | (m) | (m) | $0.00* | -$3.42M* | (m) | $2.55M | (m) | $2.00K |
|---|
| 2018-03-31 | Reported | -$4.25M | (m) | (m) | (m) | (m) | $5.00K | -$4.72M | (m) | $3.09M | (m) | $16.00K |
|---|
EBITDA 12 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2025-12-31 | Reported | -$62.03M | (m) | (m) | (m) | (m) | $302.00K | -$49.04M | (m) | $18.11M | (m) | (m) |
|---|
| 2024-12-31 | Reported | -$42M | (m) | (m) | (m) | (m) | $33.00K | -$28.85M | (m) | $14.36M | (m) | (m) |
|---|
| 2023-12-31 | Reported | -$61.01M | (m) | (m) | (m) | (m) | $112.00K | -$46.42M | (m) | $31.05M | (m) | (m) |
|---|
| 2022-12-31 | Reported | -$59.55M | (m) | (m) | (m) | (m) | $272.00K | -$52.47M | (m) | $39.83M | (m) | (m) |
|---|
| 2021-12-31 | Reported | -$42.98M | (m) | (m) | (m) | (m) | (m) | -$33.22M | (m) | $38.67M | (m) | (m) |
|---|
| 2020-12-31 | Reported | -$50.61M | (m) | (m) | (m) | (m) | (m) | -$50.73M | (m) | $34.49M | (m) | -$17.00K |
|---|
| 2019-12-31 | Reported | -$57.84M | (m) | (m) | (m) | (m) | $413.00K | -$51.15M | (m) | $41.98M | (m) | -$56.00K |
|---|
| 2018-12-31 | Reported | -$23.81M | (m) | (m) | (m) | (m) | $5.00K | -$21.05M | (m) | $16.85M | (m) | $74.00K |
|---|